Pharmaceutical

STAT+: Eye docs urge Medicare to lower insurance hurdles amid shortage of repackaged Avastin

STAT+: Eye docs urge Medicare to lower insurance hurdle...

Oct 14, 2023

Two leading ophthalmologic groups want Medicare contractors to halt practices th...

STAT+: UnitedHealth’s profit jumps as medical costs come in lower than expected

STAT+: UnitedHealth’s profit jumps as medical costs com...

Oct 14, 2023

UnitedHealth Group's profits in the third quarter jumped 11%, totaling $5.8 bill...

STAT+: HHS dispatches millions to next-generation Covid targets, including intranasal vaccine

STAT+: HHS dispatches millions to next-generation Covid...

Oct 14, 2023

HHS awards $500 million as part of Project NextGen, a $5 billion plan to develop...

Vampiric cancer cells, a brain atlas, & alleged misconduct at Cassava

Vampiric cancer cells, a brain atlas, & alleged miscond...

Oct 14, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Medicare to cover more brain scans related to Alzheimer’s drugs

STAT+: Medicare to cover more brain scans related to Al...

Oct 14, 2023

Medicare has officially expanded its coverage policy for brain scans that detect...

Kaiser Permanente reaches tentative agreement with workers

Kaiser Permanente reaches tentative agreement with workers

Oct 14, 2023

After a historic strike, healthcare giant Kaiser Permanente and the Coalition of...

STAT+: Amgen reports first clinical data on new targeted cancer therapy

STAT+: Amgen reports first clinical data on new targete...

Oct 14, 2023

It’s been a busy week for a cancer drug target called PRMT5 that may play a role...

STAT+: Pharmalittle: Makers of toxic cough syrups face new actions; Cassava suffers new blow over Alzheimer’s drug

STAT+: Pharmalittle: Makers of toxic cough syrups face ...

Oct 14, 2023

India maker of cough syrups linked to the deaths of 65 children ordered to file ...

STAT+: European regulators once again recommend Amylyx’s ALS drug be rejected

STAT+: European regulators once again recommend Amylyx’...

Oct 14, 2023

European regulators on Friday reiterated their view that an ALS treatment from A...

He was named a MacArthur ‘genius’ fellow for research on gene regulation, but still has imposter syndrome

He was named a MacArthur ‘genius’ fellow for research o...

Oct 14, 2023

MacArthur fellow Jason Buenrostro pioneered a technique that’s become a mainstay...

Opinion: Yes, everyone should get an updated Covid-19 vaccine

Opinion: Yes, everyone should get an updated Covid-19 v...

Oct 14, 2023

Yes, everyone should get an updated Covid vaccine.

STAT+: Like a vampire, some cancer cells can suck the energy source from immune cells

STAT+: Like a vampire, some cancer cells can suck the e...

Oct 14, 2023

Images reveal that cancer cells pierce T-cells with nanotubes and steal their en...

FDA fast tracks MimiVax’s glioblastoma vaccine SurVaxM

FDA fast tracks MimiVax’s glioblastoma vaccine SurVaxM

Oct 13, 2023

The US Food and Drug Administration (FDA) has granted fast track designation to...

South Rampart Pharma gains FDA fast track status for pain treatment

South Rampart Pharma gains FDA fast track status for pa...

Oct 13, 2023

South Rampart Pharma has received US Food and Drug Administration (FDA) fast tr...

Specialised Therapeutics licenses CanariaBio’s ovarian cancer antibody

Specialised Therapeutics licenses CanariaBio’s ovarian ...

Oct 13, 2023

Specialised Therapeutics (ST) has entered an exclusive agreement to license Kor...

FDA lifts clinical hold on PepGen’s myotonic dystrophy type 1 candidate

FDA lifts clinical hold on PepGen’s myotonic dystrophy ...

Oct 13, 2023

PepGen has received an all-clear from the US Food and Drug Administration (FDA)...